top button
    Got Questions


Global IoT Summit 2018
Oct 31, 2018
The Leela Palace, Bangalore



    Connect to us
      Facebook Login
      Site Registration Why to Join

Facebook Login
Site Registration

Blood Pressure Monitoring Devices & Accessories Market : Lucrative Opportunities

0 votes
5 views

Blood Pressure Monitoring Devices & Accessories Market: Introduction

Transparency Market Research has published a new report titled, ‘Global Blood Pressure Monitoring Devices & Accessories Market’. According to the report, the global blood pressure monitoring devices & accessories market was valued at ~US$ 1.9 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027.

The medical term for high blood pressure is hypertension. Blood pressure is considered to be normal under a systolic value of 140 mmHg and under a diastolic value of 90 mmHg. A blood pressure monitoring device reads blood pressure automatically based on variations in the volume of blood in the arteries. Systolic and diastolic are terms used to depict or interpret blood pressure. The blood pressure is measured in terms of millimeters of mercury (mmHg). The three stages of hypertension are prehypertension (from 120-139 over 80-90), stage 1 (from 140-159 over 90-99), and stage 2 (from 160 and above over 100 and above).

Blood Pressure Monitoring Devices & Accessories Market: Major Segments

In terms of device, the global blood pressure monitoring devices & accessories market has been segmented into sphygmomanometers, automatic blood pressure monitors, ambulatory blood pressure monitors, blood pressure transducers, and blood pressure instrument accessories. Sphygmomanometers have been categorized into mercury sphygmomanometers, aneroid sphygmomanometers, and digital sphygmomanometers. Blood pressure transducers has been classified into disposable and reusable.

Blood pressure instrument accessories have been split into blood pressure cuffs, and bladders, bulbs, and valves. The automatic blood pressure monitors segment is projected to dominate the global market during the forecast period, owing to increase in usage in different types of surgeries for different indications. User-friendliness and safe application are the major advantages of these devices. The segment held significant share of the global blood pressure monitoring devices & accessories market in 2018. The automatic blood pressure monitors segment is anticipated to expand at a moderate CAGR between 2019 and 2027, owing to rise in surgeries and adoption rate of self-serving diagnostic tools.

Request PDF Sample of Blood Pressure Monitoring Devices & Accessories Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1630

Sphygmomanometers are the other most preferred blood pressure monitors, as these are cost-effective and offer accurate readings. Growth of the sphygmomanometers segment is likely to be stable owing to decline in usage of mercury sphygmomanometers, introduction of large number of aneroid sphygmomanometers in the market, and rise in digitalization in the readings of blood pressure monitors. The blood pressure transducers and blood pressure instrument accessories segments are anticipated to witness moderate growth during the forecast period. High accuracy of blood pressure transducers, increase in the geriatric population, and favorable trade regulations in the developing countries are the major factors expected to propel the blood pressure transducers and blood pressure instrument accessories segments during the forecast period.

Based on end user, the global blood pressure monitoring devices & accessories market has been divided into hospitals, ambulatory surgical centers, clinics, home care settings, and others. The home care settings segment captured the largest market share in 2018, owing to the availability of trained & qualified personnel and favorable reimbursement structure.

The segment is expected to expand at the highest CAGR during the forecast period, attributed to the miniaturization of devices and rise in need & demand for self-testing devices by patients. Increase in the geriatric population and improvements in healthcare facilities in developing countries are anticipated to propel the clinics segment during the forecast period. However, rise in need & demand for blood pressure kiosks at public places (gym, airports, colleges, etc.) and government funding to boost the production of blood pressure monitors are likely to augment the ambulatory surgical centers and others segments during the forecast period.

Blood Pressure Monitoring Devices & Accessories Market: Prominent Regions

North America held major share of the global blood pressure monitoring devices & accessories market in 2018. Highly structured health care industry, presence of key players, and growth strategies of these players are the major factors driving the market in the region. Rise in awareness about the benefits of surgeries and procedures and increase in healthcare expenditure also contribute to the growth of the market in North America.

Asia Pacific held the second largest share of the global blood pressure monitoring devices & accessories market in 2018. Growth of the blood pressure monitoring devices & accessories market in the region can be attributed to rise in prevalence of chronic diseases and well-developed healthcare sector in the region. The market in Asia Pacific is expected to grow at a rapid pace during the forecast period. Increase in number of people with cardiovascular diseases, product approvals, and rise in awareness about cardiovascular diseases are factors anticipated to fuel the growth of the blood pressure monitoring devices & accessories market in the region.

Buy Now “Blood Pressure Monitoring Devices & Accessories Market” Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=1630&ltype=S

Blood Pressure Monitoring Devices & Accessories Market: Key Players

Key players are expanding their footprint to strengthen their positions in the global blood pressure monitoring devices & accessories market. Increase in population with hypertension offers lucrative opportunities to key players to increase their share in the blood pressure monitoring devices & accessories market. Hence, manufacturers are engaging in new product development, collaborations, and distribution to gain market share.

Leading players operating in the global blood pressure monitoring devices & accessories market include Omron Healthcare, Inc., Koninklijke Philips N.V., Schiller AG, American Diagnostic Corporation, SPENGLER, Spacelabs Healthcare, Withings SA, Welch Allyn, Inc., SunTech Medical, Inc., A&D Medical, and GE Healthcare.

More Trending Reports by Transparency Market Research –

Pulmonary Arterial Hypertension Market: globenewswire.com/news-release/2018/07/24/1541108/0/en/Pulmonary-Arterial-Hypertension-Market-to-reach-a-valuation-of-US-5-19-Bn-by-2020-Says-TMR.html

Autoimmune Disease Diagnostics Market: globenewswire.com/news-release/2018/12/07/1663722/0/en/Autoimmune-Disease-Diagnostics-Market-is-likely-to-reach-US-17-06-billion-by-2023-TMR.html

posted Feb 10 by Bella Watson

  Promote This Article
Facebook Share Button Twitter Share Button Google+ Share Button LinkedIn Share Button Multiple Social Share Button

Related Articles
0 votes

Blood Pressure Monitoring Devices & Accessories Market: Introduction

Transparency Market Research has published a new report titled, ‘Global Blood Pressure Monitoring Devices & Accessories Market’. According to the report, the global blood pressure monitoring devices & accessories market was valued at ~US$ 1.9 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027.

The medical term for high blood pressure is hypertension. Blood pressure is considered to be normal under a systolic value of 140 mmHg and under a diastolic value of 90 mmHg. A blood pressure monitoring device reads blood pressure automatically based on variations in the volume of blood in the arteries. Systolic and diastolic are terms used to depict or interpret blood pressure. The blood pressure is measured in terms of millimeters of mercury (mmHg). The three stages of hypertension are prehypertension (from 120-139 over 80-90), stage 1 (from 140-159 over 90-99), and stage 2 (from 160 and above over 100 and above).

Blood Pressure Monitoring Devices & Accessories Market: Major Segments

In terms of device, the global blood pressure monitoring devices & accessories market has been segmented into sphygmomanometers, automatic blood pressure monitors, ambulatory blood pressure monitors, blood pressure transducers, and blood pressure instrument accessories. Sphygmomanometers have been categorized into mercury sphygmomanometers, aneroid sphygmomanometers, and digital sphygmomanometers. Blood pressure transducers has been classified into disposable and reusable.

Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1630

Blood pressure instrument accessories have been split into blood pressure cuffs, and bladders, bulbs, and valves. The automatic blood pressure monitors segment is projected to dominate the global market during the forecast period, owing to increase in usage in different types of surgeries for different indications. User-friendliness and safe application are the major advantages of these devices. The segment held significant share of the global blood pressure monitoring devices & accessories market in 2018. The automatic blood pressure monitors segment is anticipated to expand at a moderate CAGR between 2019 and 2027, owing to rise in surgeries and adoption rate of self-serving diagnostic tools.

Sphygmomanometers are the other most preferred blood pressure monitors, as these are cost-effective and offer accurate readings. Growth of the sphygmomanometers segment is likely to be stable owing to decline in usage of mercury sphygmomanometers, introduction of large number of aneroid sphygmomanometers in the market, and rise in digitalization in the readings of blood pressure monitors. The blood pressure transducers and blood pressure instrument accessories segments are anticipated to witness moderate growth during the forecast period. High accuracy of blood pressure transducers, increase in the geriatric population, and favorable trade regulations in the developing countries are the major factors expected to propel the blood pressure transducers and blood pressure instrument accessories segments during the forecast period.

Based on end user, the global blood pressure monitoring devices & accessories market has been divided into hospitals, ambulatory surgical centers, clinics, home care settings, and others. The home care settings segment captured the largest market share in 2018, owing to the availability of trained & qualified personnel and favorable reimbursement structure.

The segment is expected to expand at the highest CAGR during the forecast period, attributed to the miniaturization of devices and rise in need & demand for self-testing devices by patients. Increase in the geriatric population and improvements in healthcare facilities in developing countries are anticipated to propel the clinics segment during the forecast period. However, rise in need & demand for blood pressure kiosks at public places (gym, airports, colleges, etc.) and government funding to boost the production of blood pressure monitors are likely to augment the ambulatory surgical centers and others segments during the forecast period.

Buy Now Blood Pressure Monitoring Devices & Accessories Market Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=1630&ltype=S

Blood Pressure Monitoring Devices & Accessories Market: Prominent Regions

North America held major share of the global blood pressure monitoring devices & accessories market in 2018. Highly structured health care industry, presence of key players, and growth strategies of these players are the major factors driving the market in the region. Rise in awareness about the benefits of surgeries and procedures and increase in healthcare expenditure also contribute to the growth of the market in North America.

Asia Pacific held the second largest share of the global blood pressure monitoring devices & accessories market in 2018. Growth of the blood pressure monitoring devices & accessories market in the region can be attributed to rise in prevalence of chronic diseases and well-developed healthcare sector in the region. The market in Asia Pacific is expected to grow at a rapid pace during the forecast period. Increase in number of people with cardiovascular diseases, product approvals, and rise in awareness about cardiovascular diseases are factors anticipated to fuel the growth of the blood pressure monitoring devices & accessories market in the region.

Blood Pressure Monitoring Devices & Accessories Market: Key Players

Key players are expanding their footprint to strengthen their positions in the global blood pressure monitoring devices & accessories market. Increase in population with hypertension offers lucrative opportunities to key players to increase their share in the blood pressure monitoring devices & accessories market. Hence, manufacturers are engaging in new product development, collaborations, and distribution to gain market share.

Leading players operating in the global blood pressure monitoring devices & accessories market include Omron Healthcare, Inc., Koninklijke Philips N.V., Schiller AG, American Diagnostic Corporation, SPENGLER, Spacelabs Healthcare, Withings SA, Welch Allyn, Inc., SunTech Medical, Inc., A&D Medical, and GE Healthcare.

More Trending Reports by Transparency Market Research –

ePharmacy Market: prnewswire.com/news-releases/epharmacy-market-to-reach-us128-billion-by-2023-transparency-market-research-560938961.html

Canada Home Healthcare Market: prnewswire.com/news-releases/canada-home-healthcare-market-set-to-reach-us1894-bn-by-the-end-of-2020-transparency-market-research-565741581.html

0 votes

Owing to high prevalence of cardiovascular diseases (CVD), the global ECG devices market will chart significant growth over the coming few years. And, this will be further fuelled by increasing adoption if technology over across the globe in order to improve the medical outcomes.

The global ECG devices market is sett o chart promising growth over the forecast period of 2018 and 2026, as per a Transparency Market Research study.  It is set to drive the market worth up to USD 6.79 billion by the end of the stated period.

Rise in Geriatric Population to Propel Global ECG Devices Market on a High Growth Trajectory

It is no surprise that geriatric population is seeing a massive increase. In 2018, history was created when number of people aged 65 and above surpassed the number of people aged 5 and below. Besides, by 2050, it is predicted that some 2 billion people will be 60 and above – a steep rise from 900 million in 2015.  Additionally, one in every six people in the world will be aged 65 and above by 2050 – a ratio that will be more pronounced in North America and Europe where every one in four people will belong in the said age group.

Request a PDF Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=61827

Couple this with a preference for minimally invasive diagnostic tools and one can note a rise in demand for ECG devices.

Increase in Incidence of Cardiovascular Diseases (CVD) is Generating Demand for ECG Devices Market

Stressful work lives and poor diets are leading incidence of cardiovascular diseases to go up notably. Longer work days hurt health doubly. One, stress is a severe cause. Two, longer work hours makes people eat out more than what is considered healthy. Since, not a lot of people look forward to cooking nutritious meals, using fresh ingredients, after a hard day’s work.

As per a study by World Health Organization, or WHO, by 2030, cardiovascular disease will be the leading cause of death in the world.

Buy Now ECG Monitoring Systems Market Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=61827&ltype=S

Global ECG Devices Market to Be Consolidated over the Forecast Period

The global ECG Devices Market witnesses a small number of players holding a large chunk of the market share. Some of the prominent names in the market landscape are GE Healthcare, Philips Healthcare, BioTelemetry Inc., Hill-Rom Holdings, Inc., Nihon Kohden Corporation, Schiller AG, and Spacelabs Healthcare. Others include Fukuda Denshi Co., Ltd, Mindray Medical International Limited, and CompuMed IncSome of the prominent strategies that players are opting for, in order to maintain an edge over competitors, include mergers and acquisitions and strategic partnerships and collaborations. Improving products through technological advancement also hold a prominent place in the overall scheme.

North America and Europe to Hold a Massive Market Share

Owing to rising geriatric population and presence of major players in the region will lead to the prominent position in the global ECG Devices Market.

More Trending Reports by Transparency Market Research –

Hearing Aids Market: prnewswire.com/news-releases/hearing-aids-market-increasing-prevalence-of-hearing-loss-worldwide-augments-product-demand-says-tmr-300857268.html

Diabetes Drugs Market: prnewswire.com/news-releases/diabetes-drugs-market-value-to-reach-us584-billion-by-the-end-of-2025-transparency-market-research-663610203.html

0 votes

Transparency Market Research (TMR) has published a new report titled, “Blood Transfusion Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. According to the report, the global blood transfusion diagnostics market was valued at US$ 3.0 Bn in 2016 and is projected to expand at a CAGR of 5.9% from 2017 to 2025. North America is expected to dominate the global market due to increase in adoption of new and advanced molecular tests and rise in prevalence of chronic diseases. Emerging markets such as China and India are likely to drive growth in Asia Pacific. The blood transfusion diagnostics market in the region is expected to expand at a CAGR of over 7.1% from 2017 to 2025.

Rapid Technological Advancements and Increase in Government Initiatives to Drive Global Blood Transfusion Diagnostics Market

Demand for transfusion of blood and blood components is high across the world owing to large patient population undergoing surgical procedures and suffering from chronic diseases. Introduction of new technologically advanced products and shift toward automation of instruments is projected to propel the global blood transfusion diagnostics market.

Request PDF Sample of Blood Transfusion Diagnostics Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23963

For instance, the introduction of nucleic acid amplification test (NAT) for molecular disease screening and blood typing has led to improved efficiency and reduced turnaround time. This has increased adoption of automated instruments by blood banks and hospitals, which in turn augments the global blood transfusion diagnostics market.

Organizations such as the World Health Organization (WHO), the European Blood Alliance (EBA), and Agência Nacional de Vigilância Sanitária (ANVISA) have been engaged in programs for blood transfusion safety. These initiatives are expected to strengthen the prerequisite requirements for blood screening including donor disease screening. In December 2015, Germany announced US$ 10.8 Mn for implementation and efficient adoption of its Safe Blood Transfusion Programme (SBTP).

Kits & Reagents and Disease Screening Segments to Grow at a Rapid Pace

The kits & reagents segment dominated the global blood transfusion diagnostics market in terms of revenue in 2016. The segment is anticipated to expand at a CAGR of 6.0% during the forecast period. Factors such as rise in awareness and emphasis on blood transfusion diagnostics, especially in emerging countries owing to increase in incidence of transfusion-transmitted diseases such as hepatitis C and HIV are the key factors driving the kits & reagents segment.

Enquiry for Discount on “Blood Transfusion Diagnostics Market” Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=23963

Players operating in the global blood transfusion diagnostics market focus on introduction of new instruments and kits & reagents based on new techniques. Blood transfusion diagnostics are highly used for disease screening. Rise in incidence of transfusion transmitted infections (TTIs), especially in lower-middle income and low-income countries, is the key factor augmenting the disease screening segment.

Blood Banks Segment Dominates the Market in Terms of Revenue Share

In terms of end-user, the global blood transfusion diagnostics market has been classified into hospitals, blood banks, diagnostic laboratories, plasma fractionation companies, and others. The blood banks segment held major market share in 2016. It is projected to be the fastest growing segment, expanding at a CAGR of 6.0% during the forecast period.

Increase in number of blood banks and blood centers globally, and moderate rise in the number of blood donations each year requiring donor testing and disease screening tests are the key factors driving the blood banks segment. Rise in number of patients being treated in hospital settings requiring blood transfusion and increase in patient testing and blood grouping tests being performed at hospital settings are the key factors propelling the hospitals segment.

North America to Dominate the Global Market

In terms of revenue, North America was the leading market for blood transfusion diagnostics in 2016. High percentage of active and voluntary blood donors in the U.S. and Canada, increase in number of blood transfusions per year, and various blood transfusion policies being implemented regarding safety and testing of blood for infectious diseases are attributed to North America’s high market share. The U.S. has strong policies for blood screening and the highest rate of adoption of NAT testing for donor disease screening. Europe is the second largest market for blood transfusion diagnostics.

Rise in demand for kits & reagents for pre-transfusion diagnostics and domestic manufacturers introducing new kits & reagents for disease screening and blood grouping applications are likely to accelerate the growth of the market in Europe. Increase in government initiatives in terms of funding and grants, rise in prevalence of TTIs in these countries, and surge in number of blood transfusions performed every year fuel the growth of the blood transfusion diagnostics market in Asia Pacific.

The market in Middle East & Africa was valued at US$ 350.0 Mn in 2016 and is likely to expand at a CAGR of 5.5% from 2017 to 2025. Manufacturers operating in the blood transfusion diagnostics market in Latin America are focused on offering kits and reagents that are compatible with different instruments. The low-cost high-volume nature of kits and reagents is likely to fuel the market in the region.

Key Players such as Grifols S.A., Immucor, Inc., and Bio-Rad Laboratories, Inc. Likely to Continue to Lead the Market

The report also provide profiles of leading players operating in the global blood transfusion diagnostics market. These include Bio-Rad Laboratories, Inc., Grifols S.A., Ortho Clinical Diagnostics, Abbott, F. Hoffman-La Roche Ltd., Immucor, Inc., Quotient Limited, BAG Healthcare GmBH, DiaSorin S.p.A., and Hologic, Inc. Expansion of geographical presence and partnerships for development of innovative solutions are the key strategies adopted by the key players.

In June 2017, Immucor, Inc. announced a 10-year automation agreement with CoLabs Laboratory Medicine Network to drive innovations through reagents, scalable automation, and data management solutions.

0 votes

Mass Spectrometry in Protein Biomarker Market: Important Proteomic Technology in Biomarker Discovery

Protein biomarkers are indicators which are responsible for diagnosis and treatment of different diseases, mainly, cancer. These proteins may leak from tumors to body fluids and lead to early diagnosis.

These protein biomarkers are used in diagnostic purpose as well as several research studies such as drug discovery and potential treatment option for cancer

Protein biomarkers need to be discovered for these cancer diagnosis, research, and treatment purposes. This biomarker discovery stage is followed by verification and validation steps in biomarker pipeline.

Report Overview @ https://www.transparencymarketresearch.com/mass-spectrometry-in-protein-biomarker-market.html

In discovery and verification stages, both mass spectrometry and combination of liquid chromatography and mass spectrometry can be used. Mass spectrometry has greater importance in biomarker pipeline and biomarker studies.

Key Drivers and Restraints of Global Mass Spectrometry in Protein Biomarker Market

Rise in prevalence of cancer across the world and increase in demand for protein biomarker in different disease diagnosis and treatment are some of the major factors responsible for the growth of global mass spectrometry in protein biomarker market

For instance, according to the WHO, cancer was responsible for an estimated 9.6 million deaths and was the second major cause of death globally in 2018. It is estimated that around 1 in 6 deaths occur due to cancer at global level.

Advancement of mass spectrometry instruments coupled with software is also one of the major factors attributed for the growth of global mass spectrometry in protein biomarker market

Different strategic collaborations, mergers & acquisitions among major companies and research institutes for research purpose is also propelling the global mass spectrometry in protein biomarker market

Request PDF Sample of Mass Spectrometry in Protein Biomarker Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=74163

Higher Cost of Research Activities to Hamper Mass Spectrometry in Protein Biomarker Market

It takes very high cost or expenditure for research activities of biomarker in cancer and other related studies. Hence, lack of pharmaceutical & biotechnology companies’ capability for biomarker research due to cost factor may hinder the growth of global mass spectrometry in protein biomarker market.

Lower reproducible results associated with protein assays are also a problem as these assays exhibit less reproducibility due to day-to-day variability because of multiple steps in bottom-up proteomic process.

Mass Spectrometers to be Dominant segment

Based on product type, the global mass spectrometry in protein biomarker market can be segmented into mass spectrometers, accessories, and software

Mass spectrometers dominated the global market, owing to increase in demand of instrument in proteomics and growing application in cancer research

The mass spectrometer segment is further sub-segmented into MALDI-TOF MS, Triple Quadrupole MS, Quadrupole-Trap MS, Hybrid Linear Trap Orbitrap MS, and Quadrupole-Orbitrap MS

Triple Quadrupole MS is expected to be a highly lucrative sub-segment during the forecast period, owing to its features which are relatively simple and easy-to-use with good reproducibility to offer various applications at a low cost
Research & Development Application Segment to be Highly Lucrative Segment

In terms of application, the global mass spectrometry in protein biomarker market can be divided into diagnostics, research & development, therapeutics, and others
The diagnostic segment is anticipated to dominate the mass spectrometry in protein biomarker market during the forecast period. Rise in number of cancer cases across the world and increase in trend for early disease detection by advanced diagnostic procedures are some of the major factors responsible for the growth of this segment.

The research & development segment is projected to be a lucrative segment of the global market, owing to increase in number of research activities and search of new drugs for different conditions

Pre Book “Mass Spectrometry in Protein Biomarker Market” Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=74163&ltype=S

Life Sciences Companies Segment to be More Promising

Based on end-user, the global mass spectrometry in protein biomarker market can be segmented into diagnostic centers, life sciences companies, and academic & research institutes

The life sciences companies segment is anticipated to be a more promising segment in the next few years due to growth in research activities and rise in search for drug discovery and new molecules by these companies
North America to Lead Global Mass Spectrometry in Protein Biomarker Market

In terms of region, the global mass spectrometry in protein biomarker market can be divided into: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

North America dominated the global mass spectrometry in protein biomarker market in 2018, owing to higher prevalence of cancer, higher demand of biomarkers for disease diagnosis, presence of major players engaged in mergers & acquisitions, collaboration with CROs for biomarkers, and rise in investment for R&D by companies

For instance, in August 2017, BioIVT acquired Asterand Bioscience which was focused on drug research by biomarker validation and target identification
The mass spectrometry in protein biomarker market in Asia Pacific is expected to grow with a high CAGR during the forecast period, owing to large patient pool of cancer, increase in research activities, and improving health care infrastructure in the region

Key Manufacturers Operating in Global Mass Spectrometry in Protein Biomarker Market

Key manufacturers operating in the global market are:

Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
GE Healthcare
Bruker Corporation
Advion, Inc.
IONICON
Shimadzu Corporation
PerkinElmer Inc.
LECO Corporation
DH Tech. Dev. Pte. Ltd.

More Trending Reports by Transparency Market Research –

Surgical Robots Market: https://www.prnewswire.com/news-releases/surgical-robots-market-to-reach-us13-1-bn-by-2027-as-acceptance-jumps-high-in-emerging-regions-tmr-study-300997542.html

Arthritis Therapeutics Market: https://www.prnewswire.com/news-releases/global-arthritis-therapeutics-market-to-grow-at-over-6-annually-to-reach-usd-72-billion-valuation-by-2027-transparency-market-research-300997527.html

0 votes

The global chemiluminescence immunoassay (CLIA) analyzers market was valued over US$ 4.4 Bn in 2016 and is projected to register cumulative annual growth rate (CAGR) of over 6.0% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Chemiluminescence Immunoassay (CLIA) Analyzers Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that rising demand for international accreditations and result comparability by using high-throughput automated immunoassays is spurring the growth of chemiluminescence immunoassay (CLIA) analyzers in coming years (2017 to 2025).

The North America and Europe are projected to dominate the global chemiluminescence immunoassay (CLIA) analyzers market in the coming years owing to increase in manufacturer focus for business expansion in these regions. Players are continuously developing multiplexed assay platforms and entering into distribution agreements to fortify their footprints in the North American and European markets. Growing adoption of technologically advanced products manufactured by local manufacturers like Shenzhen New Industries Biomedical Engineering Co., Ltd. is likely to drive the Asia Pacific chemiluminescence immunoassay (CLIA) analyzers market. The Asia Pacific chemiluminescence immunoassay (CLIA) analyzers market is expected to witness CAGR of over 6.5% from 2017 to 2025

Reagents Dominates the Market Followed by Automated Analyzers

The report offers detailed segmentation of global chemiluminescence immunoassay (CLIA) analyzers market based on product, application, and end-user. Among the product segment, reagents segment is poised to account for leading share of the global market during the forecast period from 2017 to 2025. Factors attributed to the higher share of the reagent segment in the global market include frequent replacements leading to increasing usage of reagents when compared to analyzer platforms. Automated analyzers segment is likely to register comparatively higher growth rate in terms of value in the global chemiluminescence immunoassay (CLIA) analyzers market during the forecast period owing to continuous innovations in the product technologies by major market players.

Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31517

Endocrine Disorders & Oncology: Top Two Application Areas of Chemiluminescence Immunoassay (CLIA) Analyzers

Among applications, endocrine disorders segment is projected to hold dominant share of global chemiluminescence immunoassay (CLIA) analyzers market during the forecast period and is likely to expand at CAGR more than 6.0% from 2017 to 2025. Major factors responsible for the dominance of this segment are continuous innovations in test offerings and wide product portfolio of major as well as local manufacturers.

For instance, in January, 2017, the world's first assay to measure free vitamin D was introduced by Future Diagnostics Solutions and DIAsource Immunoassays SA (Anteo Group). Such continuous new product launches, along with exponentially rising patient base in developed as well as developing countries are likely to drive the segment between 2017 and 2025. According to the National Institute of Diabetes & Digestive and Kidney Diseases in the U.S., nearly 4.6% of the U.S. population suffers from hypothyroidism, which highlights the significant need for advanced testing methods to diagnose the endocrine disorder. Hepatitis and retrovirus segment, accounted for more than 10.0% share of global chemiluminescence immunoassay (CLIA) analyzers market in 2016, in terms of value. It is anticipated to have substantial growth and account for approximately 12.0% of market share by 2025.

Growth of the Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Likely To Be Hinged At China, India

In terms of value, North America is likely to continue its dominance in the global chemiluminescence immunoassay (CLIA) analyzers market throughout the forecast period, owing to significant average selling prices of automated chemiluminescence immunoassay analyzers, rising demand from physicians for technologically advanced diagnostic instruments with enhanced specificity and precision, and favorable coverage as per the Clinical Laboratory Improvement Amendments for in-vitro diagnostic procedures in the region. Latin America and Middle East & Africa are relatively untapped markets having high growth potential. The governmental cap on prices of analyzers and group purchasing policies by major multispecialty hospital chains in this region is further increasing adoption of rental CLIA analyzers in these regions. Middle East & Africa chemiluminescence immunoassay (CLIA) analyzers market is characterized with significant population base demanding affordable care, and rise in governmental initiatives for early diagnosis of these chronic diseases. For instance, as per UNAIDS publication in 2016, nearly 65% of the world’s HIV infected population are present in this region.

Buy Now Chemiluminescence Immunoassay (Clia) Analyzers Market Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=31517&ltype=S

Highly Consolidated Market With Top Three Players Accounting For More Than 50.0% of the Global Market

The report also provide profiles of leading players operating in global chemiluminescence immunoassay (CLIA) analyzers market. F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthineers, and Beckman Coulter, Inc. (Danaher) are major players operating in the market, offering products with proprietary technologies, such as F. Hoffmann-La Roche Ltd.’s products are manufactured using proprietary electrochemiluminescence technology, while Abbott’s CLIA analyzers are manufactured using the chemiluminescent microparticle immunoassay technology. DiaSorin S.p.A. and Shenzhen New Industries Biomedical Engineering Co., Ltd. are the other major players in the developed and developing countries, respectively.

Expansion of tests offering in integrated digital diagnostics platform through partnerships to improve oncology and critical care treatment is a growing trend in global chemiluminescence immunoassay (CLIA) analyzers market. For instance, in January 2018, F. Hoffmann-La Roche Ltd. and GE Healthcare entered into strategic partnership to develop an industry-first digital platform, which will provide digital clinical decision support solutions in oncology and critical care treatment. Other prominent players in the global chemiluminescence immunoassay (CLIA) analyzers market include Sysmex Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics (a part of Carlyle Group), and Tosoh Corporation.

More Trending Reports by Transparency Market Research –

Automated Sample Storage Market: prnewswire.com/news-releases/automated-sample-storage-market-to-reach-us1950-million-by-2025-rising-government-support-to-remain-vital-driver-641617163.html

Menopausal Hot Flashes Market: prnewswire.com/news-releases/menopausal-hot-flashes-market-to-reach-us528-bn-by-2023-estrogen-leads-hormonal-products-in-revenue-and-prescription-volume-564235661.html

...